Search

If waste DNA or RNA remains in cells, it can lead to diseases such as Alzheimer’s and autoimmune conditions. Writing in Nucleic Acids Research, scientists led by Oliver Daumke of the Max Delbrück Center describe the role one enzyme plays in removing this waste.

When the PRDM16 gene mutates, heart muscle cells undergo changes in their metabolism. This increases the risk of congenital heart failure in women more than men, as a ECRC research team led by Sabine Klaassen and Jirko Kühnisch reports in “Cardiovascular Research.”

It borders on the miraculous how an entire animal emerges from a single egg cell. In order to understand the underlying molecular mechanisms, Markus Mittnenzweig is establishing the Computational and Developmental Biology Lab at the Max Delbrück Center.

Ten years ago, researchers at the Max Delbrück Center came up with an idea for producing synthetic fatty acids. They launched a spin-off company to develop a drug for inflammation and mitochondrial dysfunction. Now the therapeutic agent will be tested in a clinical trial. The BMBF is providing a €2.5 million grant.

Cells continually renew themselves by “digesting” unused cellular material. This mechanism is called autophagy – an area in which immunologist Katja Simon has specialized. She has devised ways to use it to slow down the aging of immune cells.

The Max Delbrück Center wants to shape the future of medicine through innovation. But turning basic research into marketable products requires gaps to be bridged. This is achieved by the Technology Transfer Office – through funding schemes such as BOOST and Pre-GoBio. The winning projects for 2023 have now been selected.

It takes great patience and perseverance to turn research findings into new technologies or therapies. The Helmholtz Initiative and Networking Fund gives financial support to “pathfinder projects” that are particularly promising. Researchers at the Max Delbrück Center have now won grants for three projects.

Berlin-based research project MSTARS is entering its second round. Matthias Selbach and Fabian Coscia explain how the Max Delbrück Center is contributing, why the collaboration with Charité is so important, and how studying proteins in cells can help identify the best therapy for a patient.

Michael Potente wants to find out what makes blood vessels grow. For his work on the metabolic regulation of such growth, he has been selected as the recipient of the 2023 Judah Folkman Award from the North American Vascular Biology Organization.

HeLa contributed to more than 75,000 studies, some of them at the Max Delbrück Center. The cell culture line is indispensable to many biomedical laboratories. But who was the woman behind this abbreviation? During Black History Month we are celebrating her legacy—and our researchers say “Thank you!”